In April, we covered NAD’s decision involving Tru Niagen, a nicotinamide riboside dietary supplement marketed to support NAD+ levels. NARB has now aff
| less than a minute read
Stay ADvised: Net Impression Matters—NAD, FTC, AGs, and NARB Turn Up the Heat
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-07-16-18-39-45-828-6a592571c623e200078a0b46.jpg)
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-07-16-18-37-10-140-6a5924d6b978db63ad34ee61.jpg)
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-07-15-18-15-51-647-6a57ce57f03bcb784b110cfb.jpg)
/Passle/68de3c97bf7349bdd953bb7f/SearchServiceImages/2026-07-13-18-13-21-029-6a552ac1747b317a3b116812.jpg)